openPR Logo
Press release

Increasing Legalization of Cannabis Drives the Cannabis Market | Key Players are Canopy Growth Corporation, Aurora Cannabis Inc., Cannabis Science Inc., Aphria Inc., Maricann Group Inc., Tilray Inc., VIVO Cannabis Inc., Medical Marijuana, Inc., Cronos Gro

01-28-2020 10:03 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: MarketsandMarkets

Cannabis Market

Cannabis Market

The report "Cannabis Market by Product Type (Flower, Concentrates), Compound (THC-Dominant, CBD-Dominant, and Balanced THC & CBD), Application (Medical and Recreational), and Region (North America, South America, Europe, and Row) - Global Forecast to 2023", The cannabis market is projected to grow from USD 10.3 billion in 2018 to USD 39.4 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 30.7% during the forecast period. The increasing legalization of cannabis and the adoption of cannabis for medicinal purposes are the key factors driving the growth of this market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=201768301

The flower segment is estimated to be the dominant segment in 2018.

The cannabis market, by product type, is estimated to be dominated by the flower segment in 2018. The dominance of this segment is largely attributable to its wider availability and its method of delivery, as smoking or vaping the cannabis flower has a quicker effect and is preferred for fast-acting relief by medical and recreational cannabis consumers. Additionally, in comparison with concentrates, flowers are able to retain a higher degree of flavor and aroma, which could be beneficial for a stronger consumer appeal. Additionally, flowers contain a higher degree of THC compounds, as they are the most unprocessed and raw form of a plant. This makes them extremely appealing for recreational purposes. These factors are expected to help the flower segment maintain a potent market share during the forecast period as well.

The recreational segment, by application, is projected to grow at a faster rate during the forecast period.

The recreational segment is projected to be the faster-growing segment, by application, during the forecast period. The recreational cannabis market is projected to remain mainly concentrated in the US and Canada. Despite its low availability in various countries, the consumption and demand levels remain equivalent to that of medicinal cannabis; due to this, the demand for recreational cannabis is projected to surpass the demand for medical cannabis. For instance, medical cannabis is legalized mainly across 33 states of the US. However, only 10 states in the country have legalized recreational cannabis, and its consumption level is almost equivalent to the consumption level of medical cannabis across the 33 states. Therefore, the legalization of recreational cannabis across other regions could translate into a larger market share for this segment.

Request for Customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=201768301

North America is projected to account for the largest market share during the forecast period.

The North American market for cannabis is estimated to account for the largest market share in 2018. The market in this region is primarily driven by growth in the US and Canadian markets. The cannabis market in this region is also driven by the increasing legalization of cannabis for both medical and recreational purposes all over North America and the increasing awareness among consumers regarding the health benefits of cannabis. The cannabis market is further fueled by the presence of major cannabis giants such as Canopy Growth Corporation, Aurora Cannabis Inc., and Medical Marijuana Inc. who are continuously investing and collaborating for the development of new products to fulfill the consumer demand.

The cannabis market is dominated by major players such as Canopy Growth Corporation (Canada), Aurora Cannabis Inc. (Canada), Tikun Olam (Israel), Cannabis Science Inc. (US), Aphria Inc. (Canada), Maricann Group Inc. (Canada), Tilray Inc. (Canada), VIVO Cannabis Inc. (Canada), Medical Marijuana, Inc. (US), STENOCARE (Denmark), Cronos Group Inc. (Canada), Terra Tech Corp. (US), and MedMen (US). MedMen is focusing on increasing its production capacity, with the use of advanced technology that is comparable to the standards used in the biotech & pharmaceutical industries for the cultivation of cannabis plants. The company wants to increase its reach by partnership and acquisitions with various dispensaries in the US. Terra Tech Corp., through its seed to sale model, keeps manufacturing low-cost cannabis to help increase profitability to capture the California, Nevada, and New Jersey markets. For instance, to capture the market in Nevada, it has secured four dispensaries, two cultivation centers, and two production & extraction facilities in the region.

Contact:
Mr. Shelly Singh
MarketsandMarkets(TM) INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
Email: sales@marketsandmarkets.com

About MarketsandMarkets(TM)

MarketsandMarkets(TM) provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets(TM) for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets(TM) are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets(TM) now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets(TM) is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Increasing Legalization of Cannabis Drives the Cannabis Market | Key Players are Canopy Growth Corporation, Aurora Cannabis Inc., Cannabis Science Inc., Aphria Inc., Maricann Group Inc., Tilray Inc., VIVO Cannabis Inc., Medical Marijuana, Inc., Cronos Gro here

News-ID: 1910562 • Views:

More Releases from MarketsandMarkets

Monoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | MarketsandMarkets™
Monoclonal Antibody (mABs) Therapeutics Market Worth $497.5 billion | Marketsand …
Monoclonal Antibody (mABs) Therapeutics Market in terms of revenue was estimated to be worth $252.6 billion in 2024 and is poised to reach $497.5 billion by 2029, growing at a CAGR of 14.5% from 2024 to 2029 according to a new report by MarketsandMarkets™. The monoclonal antibody therapeutics market is primarily driven by factors such as increasing prevalence of chronic diseases like cancer, autoimmune disorders, and infectious diseases. Technological advancements
Optometry Equipment Market Worth $6.1 billion | MarketsandMarkets™
Optometry Equipment Market Worth $6.1 billion | MarketsandMarkets™
Optometry Equipment Market in terms of revenue was estimated to be worth $4.5 billion in 2024 and is poised to reach $6.1 billion by 2029, growing at a CAGR of 6.4% from 2024 to 2029 according to a new report by MarketsandMarkets™. The principal drivers propelling the expansion of this market are the growing prevalence of eye illnesses, advancements in ophthalmic device technology, expanding government initiatives aimed at preventing visual
Cell Expansion Market Worth $26.7 billion | MarketsandMarkets™
Cell Expansion Market Worth $26.7 billion | MarketsandMarkets™
Cell Expansion Market in terms of revenue was estimated to be worth $14.3 billion in 2024 and is poised to reach $26.7 billion by 2029, growing at a CAGR of 13.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. Some factors contributing to the growth of the global market includes increasing R&D investments in cell based research, growing focus on personalized medicine, and increasing number of strategic

More Releases for Cannabis

Cannabis Market: Study Navigating the Future Growth Outlook | Aphria, Aurora Can …
An off-the-shelf report on Cannabis Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such as type/components/ application/industry verticals/ end-users are analyzed with robust research methodology which includes three step process starting with extensive secondary research to gather data from company profiles, global/regional associations, trade journals, technical
Medical Cannabis Market Size, Growth Rate, COVID-19 Impact, Key Players-Canopy G …
The Latest research study released by DBMR "Global Medical Cannabis Market" with 350+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know how of the current market development, landscape, technologies, drivers, opportunities, market viewpoint and status. This Research Report presents you analysis of market size, share, and growth, trends, and cost structure, statistical and comprehensive data of the global market. A number
Cannabis Infused Products Market Worth Observing Growth|Canopy Growth, Aurora Ca …
Cannabis Infused Products Market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to witness the growth at an annual pace of 22.0% in the forecast period. The growing awareness about the well-being and mental health benefits is driving the market scope of cannabis infused products. Cannabis infused products market is growing with the successive application of marijuana or
Cannabis Market Demand, Competitive Landscape and Outlook by 2027 Key Players - …
Cannabis or Marijuana is a psychoactive drug from the Cannabis plant used for medical or recreational purposes. Cannabis market is expected to reach US$ 153,689.9 Mn in 2027 from US$ 10,838.1 in 2018. The market is estimated to grow with a CAGR of 34.5% from 2019-2027. The report highlights the trends prevalent in the global cannabis market and the factors driving the market along with those that act as deterrents
By 2027, Cannabis Market is reaching 34.5% of CAGR Lead by Aurora Cannabis, Cann …
Global “Cannabis Market” report has implemented a systematic way to evaluate the dynamics of the overall Cannabis market. It provides a comprehensive study comprising of a top-to-bottom research on the market dynamics, including growth drivers, challenges, threats, and potential growth opportunities, with a key focus on the global market and the regional market. In a chapter-wise format, the report evaluates the global supply and demand trends in the global market,
Increasing Legalization of Cannabis Drives the Cannabis Market
The report "Cannabis Market by Product Type (Flower, Concentrates), Compound (THC-Dominant, CBD-Dominant, and Balanced THC & CBD), Application (Medical and Recreational), and Region (North America, South America, Europe, and Row) - Global Forecast to 2023", The cannabis market is projected to grow from USD 10.3 billion in 2018 to USD 39.4 billion by 2023, at a Compound Annual Growth Rate (CAGR) of 30.7% during the forecast period. The increasing legalization